Publications by authors named "Nobuo Hanai"

Claim this Profile
N
New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection.
Mizuho Kawamura, Akira Kusano, Akiko Furuya, Nobuo Hanai, Hideki Tanigaki

J Clin Lab Anal· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered therapeutic antibodies with improved effector functions.
Tsuguo Kubota, Rinpei Niwa, Mitsuo Satoh, Shiro Akinaga, Kenya Shitara, Nobuo Hanai

Cancer Sci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.
Masamichi Koike, Kazuyasu Nakamura, Akiko Furuya, Akihoro Iida, Hideharu Anazawa, Nobuo Hanai

Hum Antibodies· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Control of the physiological function of antibody by its Fc oligosaccharide structure].
Mitsuo Satoh, Kenya Shitara, Nobuo Hanai

Tanpakushitsu Kakusan Koso· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.
Andrew M Scott, Zhanqi Liu, Carmel Murone, Terrance G Johns, Duncan MacGregor, Nobuo Hanai

Cancer Immun· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
Elena I Miklyaeva, Weijia Dong, Alexandre Bureau, Roya Fattahie, Yongqin Xu, Nobuo Hanai

Brain Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.
Rinpei Niwa, Emi Shoji-Hosaka, Mikiko Sakurada, Toyohide Shinkawa, Kazuhisa Uchida, Nobuo Hanai

Cancer Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.
Yutaka Yamamoto, Jun-Ichi Yamashita, Masakazu Toi, Mariko Muta, Shigenori Nagai, Nobuo Hanai

Oncol Rep· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells.
Akiko Komiya, Hiroyuki Nagase, Hirokazu Yamada, Takashi Sekiya, Masao Yamaguchi, Nobuo Hanai

Cell Immunol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide.
Kenji Shibata, Toshiyuki Suzawa, Shiro Soga, Tamio Mizukami, Koji Yamada, Nobuo Hanai

Bioorg Med Chem Lett· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further investigation of the epitope recognized by the new monoclonal antibody 2C9.
Keitaro Kato, Kazuhiro Yoshikawa, Tomohiro Taki, Kenya Shitara, Kazuyasu Nakamura, Nobuo Hanai

Int J Urol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribonucleotide reductase immunoreactivity in adenocarcinoma cells and malignant or reactive mesothelial cells in serous effusions.
Hiroshi Okamura, Toshiaki Kamei, Nobuo Sakuma, Nobuo Hanai, Tokuhiro Ishihara

Acta Cytol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity.
Toyohide Shinkawa, Kazuyasu Nakamura, Naoko Yamane, Emi Shoji-Hosaka, Yutaka Kanda, Nobuo Hanai

J Biol Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Zhanqi Liu, Fook-Thean Lee, Nobuo Hanai, Fiona E Smyth, Antony W Burgess

Cancer Immun· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis